Expert Speaker Faculty

Take a look at the star-studded speaker faculty for the 8th Targeted Radiopharmaceuticals Summit

Guido Würth

Head of Corporate Development & Radiopharma Medical & Health; Sales; Operations
Affibody AB

Fredrik Frejd

Chief Scientific Officer
Affibody AB

Mark Dornan

Chief Executive Officer
Alpha-9 Oncology

Tanja Aarvak

Director, Program Management, Alpha Radioligand Therapy
ARTBIO

Mark Fielding

Director - Chemistry, Manufacturing, Controls, Regulatory Affairs & Radiopharmaceuticals
AstraZeneca

Sandra Hennig

Vice-President, Head of Regulatory Affairs
Bayer

Zahra Trippe

Patient Engagement Lead Oncology
Bayer

Ming Xu

Vice President, Product Team Lead, Oncology
Bayer

Kevin Tabury

Program Pipeline Manager - Head of Innovation & Translational Development Unit
Belgian Nuclear Research

Graeme McRobbie

Associate Director Formulation Science Radiopharmaceuticals
Bicycle Therapeutics plc

Michael Method

Chief Medical Officer
Bicycle Therapeutics plc

David Gauden

Chief Executive Officer
Blue Earth Therapeutics Ltd.

Kemp Dolliver

Director of Research
Brookline Capital Markets

Mohamad Haqiqian

PET Radiopharmacy Production & QC Analyst, Radiation Safety Supervisor
Curium Pharma

Christopher Jones

UK Representative to IAEA Transport Safety Standards Committee/Principal Inspector
IAEA/Office for Nuclear Regulations

Kristoffer Danielsson

CEO
Jarlen Capital

Kurt Pike

Senior Director - External Innovation
Johnson & Johnson

Cara Ferreira

Chief Executive Officer
Lumina Pharmaceuticals

Judson Kimmel

Patient Advocate
Man Up To Cancer

Gary Inwards

Sr Pharmaceutical Assessor
MHRA

Martin Steegmaier

Chief Scientific Officer
Molecular Partners

Chris Pak

President & Chief Executive Officer
Molecular Targeting Technologies

Waisi Eng

Chief Technology Officer
Norroy Bioscience CO., LTD

Ilya Folitar


Chaitanya Divgi

Sr Strategic Expert
Novartis

Ana Filipa Fonseca

Director - Global Radioligand Therapy ,Strategy & Early Portfolio
Novartis AG

Shefali Kakar

VIce President, Global Head PK Sciences - Oncology
Novartis AG

Muhammet Tanc

CEO
Nuclide Therapeutics

Rich Edwards

Chief Technology Officer
Nuclide Therapeutics

Oystein Soug

Chief Executive Officer
Oncoinvent AS

Friedmund Bachmann

Vice President - Chemistry, Manufacturing & Control
OncoOne

Frederic Desdouits

Chief Executive Officer
OranoMed

Dirk Pleimes

Group Chief Executive Officer & Chief Marketing Officer
PentixaPharm GmbH

Josie Gayton

Chief Operating Officer
Precirix

Guangzhou Han

Chief Scientific Officer
RadAlliance Therapeutics Inc

John Babich

President & Chief Scientific Officer
Ratio Therapeutics, Inc.

Dangshe Ma

Senior Director
Regeneron Pharmaceuticals

Julie Martin

President & Chief Executive Officer
Scimega Research

Richard Pearson

CEO
StandardX

Andreas Furer

Senior Regulatory Manager
Swiss Medic

Marc Robillard

Chief Scientific Officer & Founder
Tagworks Pharmaceuticals BV

Anil Lalwani

Director - Regulatory Chemistry Manufacturing & Controls & MedTech
Telix Pharmaceuticals

Ajaaz Hussain

Radiopharmaceutical Scientist (Clinical Trials)
The Royal Marsden NHS

Tinashe Chandauka

Co-Founder & Chief Executive Officer
TMab Therapeutics

Luke Brzozowski

Executive Director - Translational Research & Core Facilities ,Program Sponsor, Theranostics
UHN

Julia Publicover

Director, Translational Research & Innovation
University Health Network

Luigi Aloj

Professor of Nuclear Medicine
University of Cambridge

Haihong jin

Chief Scientific Officer
Vitsgen Therapeutics, Inc.
Conference Image
Explore the Agenda

Discover the scientific, clinical and commercial strategies that will become your blueprint for accelerating targeted radiopharmaceuticals from discovery to patients.

View Presentations & Speakers
Conference Image
Partner With Us

Showcase your technologies and services to 200+ senior decision-makers actively seeking CROs, CDMOs, isotope suppliers, radiopharmacies, dosimetry providers and specialist partners to advance the next generation of radiopharmaceuticals.

Explore Sponsorship Options
Conference Image
Join Europe's TRP Leaders:

Be part of Europe's most comprehensive targeted radiopharmaceuticals forum, uniting pharma, biotech, regulators, clinical centres, investors and solution providers to shape the future of radioligand therapy.

Register Now